Biotalys NV (BTLS.BR)
EUR 3.08
(0.98%)
EUR 3.08
(0.98%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -18.28 Million | -20.09 Million | -16.75 Million | -9.53 Million | -8.22 Million |
| Net Income | -20.89 Million | -22.53 Million | -18.07 Million | -13.27 Million | -9.24 Million |
| Depreciation & Amortization | 1.78 Million | 1.57 Million | 1.47 Million | 1.03 Million | 594 Thousand |
| Deferred income taxes | - | - | -449 Thousand | 13 Thousand | 1000.00 |
| Stock-based compensation | 1.03 Million | 1.73 Million | 511 Thousand | 550 Thousand | 157 Thousand |
| Change in working capital | 418 Thousand | -21 Thousand | -214 Thousand | 2.56 Million | 541 Thousand |
| Other non-cash items | 115 Thousand | -847 Thousand | 7000.00 | -424 Thousand | -275 Thousand |
| Investing Cash Flow | 233 Thousand | -684 Thousand | -1.32 Million | -6.01 Million | -641 Thousand |
| Investments in PPE | -455 Thousand | -707 Thousand | -1.33 Million | -3.93 Million | -645 Thousand |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | -2.1 Million | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | 1000.00 | 23 Thousand | 8000.00 | 15 Thousand | 4000.00 |
| Financing Cash Flow | 5.53 Million | -1.24 Million | 51.08 Million | 15.29 Million | 24.45 Million |
| Debt repayment | -1.27 Million | -1.23 Million | -1.12 Million | -1.02 Million | -565 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 6.96 Million | 236 Thousand | 49.67 Million | 15.13 Million | 19.93 Million |
| Other Financing Activities | 1000.00 | -245 Thousand | 2.53 Million | 1.18 Million | 5.08 Million |
| Accounts receivables | 89 Thousand | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | 329 Thousand | - | - | - | - |
| Cash at beginning of period | 34.09 Million | 56.1 Million | 23.1 Million | 23.35 Million | 7.77 Million |
| Cash at end of period | 21.57 Million | 34.09 Million | 56.1 Million | 23.1 Million | 23.35 Million |
| Capital Expenditure | -455 Thousand | -707 Thousand | -1.33 Million | -3.93 Million | -645 Thousand |
| Effect of forex changes on cash | -5000.00 | 6000.00 | -1000.00 | -1000.00 | 1000.00 |
| Net cash flow / Change in cash | -12.52 Million | -22.01 Million | 33 Million | -255 Thousand | 15.58 Million |
| Free Cash Flow | -18.73 Million | -20.79 Million | -18.08 Million | -13.46 Million | -8.86 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3244.50 | -3244.50 | -4923.00 | -20.89 Million | -4923.00 | -5332.00 |
| Depreciation & Amortization | 459.00 | 459.00 | 449.00 | 1.78 Million | 449.00 | 444.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 174.00 | 174.00 | 157.00 | 1.03 Million | 157.00 | 361.50 |
| Change in working capital | -35.00 | -35.00 | -96.00 | 418 Thousand | -96.00 | 1101.00 |
| Other non-cash items | -617.00 | -617.00 | -470.50 | 115 Thousand | -470.50 | -832.50 |
| Investing Cash Flow | 110.50 | 110.50 | 106.50 | 233 Thousand | 106.50 | 10.00 |
| Investments in PPE | -46.50 | -46.50 | -58.50 | -455 Thousand | -58.50 | -112.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 157.00 | 157.00 | 165.00 | 1000.00 | 165.00 | 122.00 |
| Financing Cash Flow | -292.00 | -292.00 | -379.50 | 5.53 Million | -379.50 | 3144.50 |
| Debt repayment | - | - | - | -1.27 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -27.00 | - | -27.00 | - |
| Common Stock Issuance | - | - | - | 6.96 Million | - | - |
| Other Financing Activities | -292.00 | -292.00 | -352.50 | 1000.00 | -352.50 | 3144.50 |
| Accounts receivables | 36.50 | 36.50 | -179.00 | - | -179.00 | 223.50 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -71.50 | -71.50 | 83.00 | - | 83.00 | 877.50 |
| Cash at beginning of period | - | - | - | 34.09 Million | 31.88 Thousand | 32.99 Thousand |
| Cash at end of period | -3445.00 | -3445.00 | -5158.00 | 21.57 Million | 26.72 Thousand | 31.88 Thousand |
| Capital Expenditure | -46.50 | -46.50 | -58.50 | -455 Thousand | -58.50 | -112.00 |
| Effect of forex changes on cash | - | - | -1.50 | -5000.00 | -1.50 | -1.00 |
| Net cash flow / Change in cash | -3445.00 | -3445.00 | -5158.00 | -12.52 Million | -5158.00 | -1104.50 |
| Free Cash Flow | -3310.00 | -3310.00 | -4942.00 | -18.73 Million | -4942.00 | -4370.00 |
ENGI
WTM
RSCZF
6292
MRK
300796